Showing 451-460 of 3844 results for "".
Part 4, 1726 nm lasers: Handling referred patients who are already on different treatment regimens
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24342/Chapter 4 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about handling referred patients who are already on different treatment regimens.Part 7, 1726 nm lasers: When a patient doesn’t improve: Doctors discuss “pearls” of wisdom
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24345/Chapter 7 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about when a patient doesn’t improve: Doctors discuss “pearls” of wisdom.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 6
https://practicaldermatology.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-6/56874/In the sixth installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, discuss patient adherence, tolerability, and the importance of simple, non-irritating regimens in achieving real-world success.1 Draelos Z, HougeirFDA Approval for Delgocitinib
https://practicaldermatology.com/series/c-suite-chats/fda-approval-for-delgocitinib/36650/Robert Spurr, EVP, North America for LEO Pharma, discusses the importance of an FDA-approved option for treating moderate-to-severe chronic hand eczema in adults.The Impact of Clascoterone Topical Cream, 1%: The US Experience 4 Years After Approval and Clinical Expectations for Acne Patients in Other Regions of the World
https://practicaldermatology.com/topics/acne-rosacea/Impact-Clascoterone-Topical-Cream/32830/Clascoterone topical cream, 1% (Winlevi), approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older. The safety and efficacy were supported by two succeDefending Sunscreens
https://practicaldermatology.com/topics/skin-cancer-photoprotection/defending-sunscreens/19980/Sunscreen controversies have been a hot topic leaving patients with many questions about its safety and proper use. Adam Friedman, MD offers tips for talking to patients about what is really needed in an SPF, applying the right amount of sunscreen for adequate protection, and discussing data to helpIlluminate Psoriasis Pathogenesis
https://practicaldermatology.com/topics/psoriasis/illuminate-psoriasis-pathogenesis/19936/Discover a novel view of the complex interplay between proinflammatory cytokines that contribute to psoriasis pathogenesis.How Do You Educate Patients about Chronic Blushing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-do-you-educate-patients-about-chronic-blushing/19825/Dr. Friedman tackles "a doozy of a question" with advice on how to educate patients about signaling gone awry and strategies for long-term care.What is Your Approach to Hair Loss in Women?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/what-is-your-approach-to-hair-loss-in-women/19821/A seemingly simple question belies the complexity of managing hair loss. Dr. Friedman describes tactics from showing empathy to implementing treatments.A New Option for Estrogen Deficient Skin
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-new-option-for-estrogen-deficient-skin-/19587/Post-menopausal women often experience dryness, thinning, and atrophy of the skin as a result of estrogen deficiency, Diane Berson, MD says. She discusses a new cosmeceutical now available that helps to non-hormonally restore the natural function of estrogen deficient skin.